Q2 2026 saw 5.2% revenue growth, margin expansion, and a 53% rise in non-GAAP EPS, driven by cost actions and strong bookings. FY 2026 guidance was raised for EPS and margins, with robust performance in semiconductor and security segments.Original document: Bruker Corporation [BRKR] Slides Release…
Q2 2026 saw 5.2% revenue growth, margin expansion, and a 53% rise in non-GAAP EPS, driven by cost actions and strong bookings. FY 2026 guidance was raised for EPS and margins, with robust performance in semiconductor and security segments.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
